Future Science OA · 2018 · 22 citations · 25 references
Veterinary MedicineInfectious DiseasesMicrobiologyHost-pathogen InteractionsMedical MicrobiologyMicrobial PathogenesisAntifungal AgentsAntifungal TherapyAntimicrobial TherapyBiofilm Formation In InfectionFungal InfectionsOral CandidiasisCandida Albicans InfectionCandida BiofilmsCandida TherapyCryptococcosis TherapyMurine Models
Aim: In this work we test 2-(2-(cyclohexylmethylene)hydrazinyl)-4-phenylthiazole (CHT) against Cryptococcus spp. and Candida albicans. Methods: The ability of CHT to act in biofilm and also to interfere with C. albicans adhesion was evaluated, as well as the efficiency of the CHT in cryptococcosis and candidiasis invertebrate and murine models. Results & conclusion: In the present work we verified that CHT is found to inhibit Cryptococcus and C. albicans affecting biofilm in both and inhibited adhesion of Candida to human buccal cells. When we evaluated in vivo, CHT prolonged survival of Galleria mellonella after infections with Cryptococcusgattii, Cryptococcusneoformans or C. albicans and promoted a reduction in the fungal burden to the organs in the murine models. These results demonstrate CHT therapeutic potential.
25
John R. Perfect, William E. Dismukes, Françoise Dromer et al. · Clinical Infectious Diseases · 2010 · 2.7K citations · Full text
Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay
Julia Breger, Beth Burgwyn Fuchs, George Aperis et al. · PLoS Pathogens · 2007 · 326 citations · Full text
Methods for using<i>Galleria mellonella</i>as a model host to study fungal pathogenesis
Beth Burgwyn Fuchs, E.N. O'Brien, Joseph El Khoury et al. · Virulence · 2010 · 318 citations · Full text